<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00573365</url>
  </required_header>
  <id_info>
    <org_study_id>UCI 06-46</org_study_id>
    <secondary_id>2006-5251</secondary_id>
    <nct_id>NCT00573365</nct_id>
  </id_info>
  <brief_title>LED Photomodulation for Prevention of Post-Radiation Treatment Dermatitis</brief_title>
  <official_title>LED Photomodulation for Prevention of Post-Radiation Treatment Dermatitis: A Prospective, Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Radiation dermatitis is a common side-effect of radiation therapy in cancer patients who&#xD;
      frequently can experience redness, pain, crusting, and even ulceration of the skin causing&#xD;
      suffering and treatment interruption. A recent retrospective study by DeLand demonstrated&#xD;
      that administering light emitting diode (LED) photomodulation after each radiation treatment&#xD;
      for breast cancer decreased radiation dermatitis in a majority of patients. LED&#xD;
      photomodulation is a process by which specific sequences of light are used to regulate or&#xD;
      manipulate cell activity without causing heat or damage to the skin. Each LED treatment is&#xD;
      painless and is completed in usually less than one minute. LED photomodulation may reduce the&#xD;
      suffering associated with radiation treatments, improve cosmetic outcome in radiation fields,&#xD;
      and eliminate breaks in radiation treatments which may be required because of severe&#xD;
      ulcerating reactions.&#xD;
&#xD;
      This study will attempt to replicate the findings of Dr. DeLand's study by randomly assigning&#xD;
      at least 40 breast cancer patients to either a treatment group or to a control group. The&#xD;
      treatment group will receive LED photomodulation treatments before and after each radiation&#xD;
      treatment with the Gentlewaves Select™ handheld high energy 590nm LED array using specific&#xD;
      sequences of pulses used in other studies; the treatment group will also receive 7 additional&#xD;
      treatments over 2 weeks after their radiation treatment course is completed. The control&#xD;
      group will receive no LED treatment but will use the exact same skin care regimen as the&#xD;
      treatment group. In addition to weekly evaluation and grading of skin reactions, subjects&#xD;
      will be photographed under standardized conditions weekly and then photographs will be&#xD;
      evaluated and graded by blinded dermatologists.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The enrollment goal of 40 includes 20 for each arm.</intervention_model_description>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine efficacy</measure>
    <time_frame>6 years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Radiation Dermatitis</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LED treatment with Gentlewaves Select™ handheld high energy LED array 5 to 10 minutes before each radiation treatment and again 5-10 minutes after each radiation treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Radiation only</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Gentlewaves Select™ handheld high energy LED array</intervention_name>
    <description>LED photomodulation within 5-10 minutes before and within 5-10 minutes after each radiation treatment</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiation</intervention_name>
    <description>Weekly radiation treatment</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiation</intervention_name>
    <description>Weekly radiation treatment</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects must have clinically diagnosed breast or head and neck cancer that will be&#xD;
             treated with radiation therapy.&#xD;
&#xD;
          -  Subjects must be at least 18 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects will not be eligible to participate if they are pregnant or lactating.&#xD;
&#xD;
          -  Patients treated with partial breast irradiation techniques, brachytherapy, or other&#xD;
             non-standard techniques will not be eligible.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Douglas Fife, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chao Family Comprehensive Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chao Family Comprehensive Cancer Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <study_first_submitted>December 12, 2007</study_first_submitted>
  <study_first_submitted_qc>December 13, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2007</study_first_posted>
  <last_update_submitted>August 1, 2017</last_update_submitted>
  <last_update_submitted_qc>August 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Chao Family Comprehensive Cancer Center</investigator_full_name>
    <investigator_title>Cancer Center</investigator_title>
  </responsible_party>
  <keyword>dermatitis</keyword>
  <keyword>skin</keyword>
  <keyword>radiation</keyword>
  <keyword>light</keyword>
  <keyword>LED photomodulation</keyword>
  <keyword>Gentlewaves</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Radiodermatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

